Wellness & Lifestyle

SpermTracer by ReproScientifics is an innovative AI technological software designed to support fertility experts and embryologists in evaluating spermatozoa for ICSI in real-time. The tool leverages Artificial Intelligence and Big Data to improve sperm selection, addressing the subjectivity and inconsistencies of manual methods. It analyzes both motility and morphology, even in challenging samples like severe oligozoospermia, azoospermia, and those from invasive procedures (micro-TESE, TESA, PESA, MESA). The software utilizes a Deep Neural Network (DNN) architecture, allowing it to adapt and improve with more data, offering more accurate, consistent, and objective sperm analysis than conventional methods. SpermTracer is intended to be a valuable tool that works in synergy with embryologists' expertise, promoting standardization and consistency in sperm selection, and is applicable with various sperm selection techniques.

Deep Forest Sciences has developed Prithvi, an AI assistant designed to accelerate scientific discoveries in medicine and materials. Powered by the DeepChem infrastructure, Prithvi utilizes large scientific foundation models and cutting-edge AI techniques on proprietary data to provide AI-driven insights. It has been successfully deployed on various projects including drug discovery, energy, and molecular design. The platform also supports no-code fine-tuning of chemical foundation models, relative binding free energy calculations, molecular dynamics, and DEL-ML analysis, making advanced scientific AI accessible to researchers.

Premium Research is a company specializing in key areas such as artificial intelligence, including machine learning, computer vision, and digital twins. They also focus on bioinformatics, biostatistics, omics and metabolomics studies, genetics, and nanotechnology. The company develops European and national R&D+i projects funded by public grants, such as Horizon Europe and national PERTE and CDTI programs. Additionally, Premium Research offers services in the production of scientific articles, brochures, and specialized posters. In open innovation, they excel in technology watch, community building, and collaboration networks, with a special focus on innovative startups.

Phases is an AI-powered platform designed to revolutionize clinical trial operations by deploying AI agents for continuous oversight and execution. It connects to existing trial systems like EDC, TMF, and CTMS to monitor, analyze, and proactively address emerging risks and issues. The platform boasts 98% risk and deviation detection accuracy, ensuring continuous trial oversight with zero gaps. Phases automates tasks such as TMF coverage, query management, and regulatory document filing, significantly reducing delays and improving audit readiness. It is compliant with HIPAA and 21 CFR Part 11, with SOC 2 audit in progress, and ensures customer data is never used to train its AI models.

ScreenPoint Medical's Transpara Breast AI is an industry-leading artificial intelligence solution designed to enhance breast cancer detection and streamline workflow for radiologists. It supports both 2D and 3D mammograms, offering earlier detection and improved efficiency. The technology is built to evolve continuously with innovative products and enhanced algorithms, backed by extensive independent peer-reviewed publications and participation in randomized controlled trials. Transpara is FDA cleared and CE marked, providing vendor-agnostic solutions that integrate seamlessly into existing clinical workflows, whether for single or double reading environments. It aims to address challenges like radiologist shortages and rising patient volumes by acting as a 'second pair of eyes,' increasing confidence and improving patient outcomes across various demographics and breast densities.

Verge Genomics has pioneered an advanced all-in-human AI-powered drug discovery platform, focusing on developing new drugs for major medical challenges. The platform leverages human genomics, machine learning, biological engineering, and translational medicine to decipher disease biology. Instead of relying on animal or cell models, Verge Genomics utilizes one of the world's largest proprietary multi-omics databases derived directly from human tissue. This approach allows them to map complex disease causes and develop proprietary drug candidates. Their first drug, VRG50635, for amyotrophic lateral sclerosis (ALS), moved from research to clinic in just four years, demonstrating the platform's efficiency. They are also working on treatments for Parkinson's Disease and Frontotemporal Dementia.

ClosedLoop is a leading healthcare AI platform designed to help organizations improve health outcomes and reduce unnecessary costs. It provides accurate, explainable, and actionable predictions of individual-level health risks, enabling proactive interventions. The platform features predictive analytics for providers, ACOs, payers, pharma, and digital health companies. ClosedLoop offers data science automation to streamline data preparation and accelerate AI/ML deployments, along with a comprehensive healthcare content library of modifiable templates for predictive models and data transformation. This allows for faster time to value and greater impact in clinical and financial outcomes.

AKASA offers generative AI (GenAI) solutions specifically designed for the healthcare revenue cycle, aiming to transform operations by reducing denials, improving financial margins, and increasing revenue. The platform leverages advanced GenAI, trained on extensive clinical and financial data, to empower healthcare revenue cycle staff. Key offerings include a Prebill Optimization Suite for unifying coding and Clinical Documentation Improvement (CDI), a Coding Optimizer to surface missed opportunities and boost revenue integrity, and a CDI Optimizer that acts as a GenAI assistant to uncover documentation gaps. Additionally, AKASA provides an AI Advisor for quick access to information, Auth Status for automated authorization checks, and Claim Status for up-to-date claim information, all contributing to faster speed-to-value and decreased cost-to-collect.

CarePredict is an AI-powered platform designed to enhance senior care across various settings, including assisted living, independent living, homecare, and memory care. The tool offers real-time care visibility and predictive health analytics, leveraging AI to detect subtle behavioral changes for earlier interventions. Key features include fall detection, wander management, resident safety alerts, and geo-fencing. It also provides tools for staff empowerment, aiming to reduce turnover through improved communication and documentation. CarePredict helps optimize care plans by tracking services provided and supports predictive health decline prevention, ultimately working to reduce hospitalizations and improve resident well-being. The platform is built to integrate with existing Electronic Health Records and offers solutions for capturing unbilled care services.

KOL Pulse AI is an AI-powered platform designed for oncology intelligence, offering real-time insights into Key Opinion Leaders (KOLs) and clinical trials. It provides verified social intelligence from major oncology conferences, clinical trials, and OpenPayments data, ensuring all insights are sourced, cited, and audited. The platform features AI-generated trial intelligence with real slides and KOL commentary, including sentiment analysis and engagement leaderboards. Users can track KOL sentiment, influencer networks, and social engagement maps. KOL Pulse AI also offers 26 embeddable widgets for integrating live KOL intelligence into any website or AI platform, making it accessible for medical affairs, insights, and med comms teams.

CapeStart offers a suite of AI services, data annotation, and software development solutions tailored for enterprises in healthcare, telecom, finance, manufacturing, retail, and legal industries. Their award-winning MadeAi™ Platform serves as the foundation for GenAI services and bespoke customer solutions, leveraging years of AI knowledge and expertise. The company provides data annotation for text, audio, video, and medical images, alongside ML & AI model development. Additionally, CapeStart delivers technology services including machine learning, mobile applications, web solutions, data engineering, data science, and GenAI, ensuring comprehensive coverage of technology needs. They also offer Research & Analysis Services and Medical Image Annotation Services across various imaging modalities.

CarePlix is a global leader in rPPG and face scan vital signs technology, offering clinical-grade contactless vital signs monitoring using smartphone cameras. With 98.32% clinical accuracy and a dataset of over 50 million patients, CarePlix provides a robust platform for digital health. The company offers solutions like Unity Health for enterprise health data with 35+ biomarkers, CarePlix ONE for consumer wellness with face scan vitals, and Semantic OS for AI-powered healthcare workflow automation. CarePlix is ISO 13485, ISO 27001, and SOC 2 Type II certified, and is HIPAA compliant, US FDA Registered, and CDSCO Registered, ensuring high standards for medical device quality and data security.

Aiku specializes in enabling individuals and teams to innovate and build with AI, moving beyond theoretical concepts to practical implementation. Their services encompass data engineering, machine learning, and data automation, designed to guide clients through every stage of their AI journey. Aiku helps lay the foundation for data analytics by organizing data pipelines and providing ready-to-use data. They also assist in leveraging artificial intelligence and predictive models to gain critical insights for better decision-making. Furthermore, Aiku supports the publication of data products through interactive web applications and provides ongoing service and support for software deployment and maintenance. They offer specialized solutions for marketing, sales, production, and research & development, including custom machine learning and data mining services.

Facere AI is an AI-powered workflow automation tool specifically designed for the healthcare industry. It aims to significantly improve efficiency and patient care by automating various administrative tasks. The platform is capable of streamlining operations in mental health clinics, GP practices, and radiology centers. Key functionalities include automating patient communication, efficiently handling both inbound and outbound calls, and managing appointment bookings. By offloading these repetitive tasks, Facere AI allows healthcare professionals to focus more on patient care, ultimately enhancing the overall operational effectiveness of healthcare organizations.

InnoDeep is an augmented intelligence platform designed to enhance precision diagnosis by integrating AI with human expertise. The platform leverages deep learning to assist radiologists in achieving higher accuracy and faster diagnosis times. Key features include a remote and intelligent diagnosis system, a 3D reconstruction tool crucial for preoperative tumor evaluation, and a digital e-reporting system providing comprehensive diagnostic imaging results. InnoDeep aims to address the shortage of radiologists globally, particularly in African countries, by offering remote technology and AI to reduce diagnosis time and cost, while improving healthcare services. The platform also supports the evaluation of radiotherapy and chemotherapy efficacy and offers a collaborative environment for healthcare professionals.

Ataraxis AI is an AI precision medicine company dedicated to transforming cancer care through advanced artificial intelligence. The platform empowers physicians with multi-modal tools to enhance treatment selection and improve patient outcomes. Ataraxis Breast, their flagship offering, provides clinically validated prognostic and predictive tools specifically for breast cancer, including recurrence risk, chemotherapy benefit, and neoadjuvant response. The technology leverages cutting-edge AI foundation models, such as Falcon, trained on vast pan-cancer pathology slide images to discover novel clinical, morphological, and molecular features. Unlike traditional molecular genomic tests, Ataraxis AI delivers results within 24 hours without exhausting physical tissue, offering a rapid and efficient solution for cancer diagnostics and treatment planning.

Insightin Health offers inGAGE™, an AI-driven digital health platform designed for healthcare payers to enhance member engagement, acquisition, and retention. The platform eliminates data silos by integrating structured and unstructured data into a highly secured, compliant system. Utilizing artificial intelligence and machine learning, inGAGE™ provides real-time predictions and a 360-degree view of members, enabling insights for closing care gaps, managing chronic conditions, and improving member support. It delivers proactive, personalized recommendations and campaigns, driving significant results such as 99% prediction accuracy and substantial PMPM savings. The platform supports Medicare, Medicaid, and ACA/Commercial solutions, helping organizations achieve lifetime member value and increased profitability.

MarkiTech.AI is a Canadian company specializing in AI-driven digital healthcare solutions, offering specialized AI agents, clinical workflow platforms, and custom healthcare software. Their flagship product, CliniScripts, is an AI clinical copilot designed for mental health, ABA, OT/PT/SLP, pediatrics, nursing homes, correctional health, and EAPs, providing real-time multilingual transcription, ICD-10 auto-coding, and EMR-agnostic integration. MarkiTech.AI also provides solutions for AI reception, scheduling, fax workflows, remote monitoring, and telemedicine. All products are built with regulatory compliance (ISO 27001, PHIPA, HIPAA) at their core, ensuring secure and scalable systems that lighten administrative work, improve patient outcomes, and help healthcare providers grow with confidence.

MATA MEDICAL DATA is a French company dedicated to advancing medical imaging through artificial intelligence. The platform provides an AI chatbot specifically designed to support radiologists in their daily tasks. This includes assisting with diagnostic processes and streamlining the generation of medical reports. By leveraging AI, MATA MEDICAL DATA aims to significantly reduce the workload on healthcare professionals, allowing them to focus more on critical patient care. The tool also strives to improve the accuracy and efficiency of medical imaging analysis, ultimately contributing to better patient outcomes. Its focus on automating routine tasks helps optimize clinical workflows within medical facilities.

New Port LLC, operating as NewportAI, is an AI company that delivers a comprehensive multimodal AI platform for enterprise clients. Their core offerings include digital avatar creation for video, live-chat, and physical hardware, alongside advanced voice and image generation capabilities. Key products and services include DreamAPI for AI-powered video, audio, and image creation, DreamFace for one-click AI video generation, and Teameet for AI-enhanced video meetings. They also feature an AI Fitting Mirror for virtual try-ons and Live-Chat Avatars for customer service and recruitment. NewportAI focuses on scaling content and interactions with zero latency, catering to businesses looking to integrate sophisticated AI into their operations.

OPTT Health offers a revolutionary AI toolkit designed to improve behavioral health outcomes by analyzing patient narratives. The platform provides actionable insights to mental health provider teams, enabling them to deliver high-quality care more efficiently. Its AI-backed solutions augment traditional practices, helping providers triage, access, and monitor patients' progress effectively. Key differentiators include instant matching to the right level of care using AI/NLP algorithms, higher patient engagement through tailored care pathways, and clinically validated tools proven through rigorous trials. OPTT Health supports a digital-first approach, streamlining care processes and enhancing digital care strategies with features like continuous engagement and proactive treatment plans.

Jatayu Healthcare Technologies develops AI/ML-based products to streamline healthcare processes, focusing on reducing contact points and enabling voice-controlled commands. Their flagship product, VoiceDocAI, is an AI-driven dictation application designed for the healthcare industry, boasting 95% accuracy for medical report generation. It supports Indian English with various accents and incorporates an extensive library of medical terminology and specialty-specific vocabulary. VoiceDocAI's AI-NLP technology comprehends context, medical phrases, acronyms, and abbreviations, minimizing the need for extensive editing. The application is available in both cloud and on-premise formats, offering flexibility to healthcare professionals.

Mind Storms is at the forefront of the brain-to-computer interface revolution, offering a revolutionary approach to mind-computer interaction. The technology translates thoughts into spoken language, making BCI accessible and affordable for all. It supports both medical and commercial headsets, ensuring easy adoption of assistive technology. Mind Storms' Brain Waves to Spoken Language technology is particularly beneficial for patients with Locked-In Syndrome (LIS), ALS, and other neuro-motor disabilities, empowering them to communicate. Using cutting-edge neuroscience and generative AI, the platform provides a seamless way to interact with computers and restore voices thought to be lost forever. The mission is to make BCI technology accessible, converting thoughts into text and speech through deep learning.

Keebler Health is an AI-first risk adjustment platform designed for healthcare providers and payers who manage Medicare and Medicaid populations. The platform leverages a next-generation AI transformer specifically built for Risk Bearing Entities, offering fast, simple, and easy integration. It provides risk adjustment opportunities with high transparency, showing confidence, evidence, and counterfactual support. Keebler Health aims to boost the entire team, amplifying the efforts of CDI, Coding, and Audit Teams through features like pre-visit planning and HCC coding workflows. The platform integrates various data sources, from faxes to FHIR, and is designed to work effectively even with dirty data, thanks to its transformer technology. It also supports HIE integrations and is v28 Out-of-the-Box, allowing for native HCC codeset changes.